Centessa Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	383.22	128.03	393.64	595.08	7.23
Short-Term Investments	98.96	128.52	-	-	-
Cash & Short-Term Investments	482.18	256.55	393.64	595.08	7.23
Cash Growth	87.95%	-34.83%	-33.85%	8134.15%	-
Other Receivables	45.3	39.15	26.72	16.81	2.93
Receivables	45.3	39.15	26.72	16.81	2.93
Prepaid Expenses	0.84	1.65	2.79	4.66	0.01
Other Current Assets	8.1	17.74	14.59	12.22	1
Total Current Assets	536.41	315.09	437.75	628.77	11.17
Property, Plant & Equipment	11.76	12.95	1.17	0.16	-
Long-Term Deferred Tax Assets	26.59	29.65	3.51	-	-
Other Long-Term Assets	2.05	2.55	1.88	0.7	0.55
Total Assets	576.8	360.25	444.31	629.64	11.72
Accounts Payable	7.14	11.82	13.84	8.07	1.03
Accrued Expenses	49.31	26.62	22.23	15.7	1.04
Short-Term Debt	-	-	-	-	5.63
Current Portion of Leases	0.6	-	-	-	-
Current Income Taxes Payable	0.84	0.11	1.58	0.77	-
Other Current Liabilities	0.11	0.84	0.69	0.1	0.92
Total Current Liabilities	58	39.39	38.34	24.64	8.62
Long-Term Debt	108.94	75.7	69.8	75.7	-
Long-Term Leases	8.29	8.89	-	-	-
Other Long-Term Liabilities	0.03	0.03	-	37.74	-
Total Liabilities	175.25	124	108.14	138.08	8.62
Common Stock	0.36	0.27	0.27	0.25	25.55
Additional Paid-In Capital	1,386	987.42	939.26	876.27	0.83
Retained Earnings	-988.7	-752.95	-601.86	-385.65	-23.85
Comprehensive Income & Other	4.21	1.49	-1.5	0.69	0.57
Shareholders' Equity	401.55	236.24	336.17	491.55	3.1
Total Liabilities & Equity	576.8	360.25	444.31	629.64	11.72
Total Debt	117.83	84.59	69.8	75.7	5.63
Net Cash (Debt)	364.35	171.96	323.84	519.38	1.6
Net Cash Growth	111.88%	-46.90%	-37.65%	32361.38%	-
Net Cash Per Share	3.18	1.79	3.47	6.91	0.11
Filing Date Shares Outstanding	133.18	100.31	94.96	94.02	15
Total Common Shares Outstanding	132.63	98.77	94.84	89.99	15
Working Capital	478.41	275.71	399.41	604.14	2.55
Book Value Per Share	3.03	2.39	3.54	5.46	0.21
Tangible Book Value	401.55	236.24	336.17	491.55	3.1
Tangible Book Value Per Share	3.03	2.39	3.54	5.46	0.21
Machinery	1.54	1.5	0.44	0.2	-
Construction In Progress	-	-	0.89	-	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q